5299 篇
13868 篇
408774 篇
16079 篇
9269 篇
3869 篇
6464 篇
1238 篇
72401 篇
37108 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4866 篇
3821 篇
5293 篇
全球躁郁症治疗市场报告(2015-2019年)
Global Bipolar Disorder Therapeutics Market 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Disease overview
Understanding the disorder
Types of bipolar disorder
Causes
Signs and symptoms
Management
Self-help
Epidemiology
PART 06: Pipeline analysis
ITI-007
FK949E
PROCYCLOX
RP5603
CNV1061436
LY2979165
DP-VPA
SKL-PSY
PGW-5
DLP-114
DLP-115
Small molecule targeting GPR78
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by drug class
Mood stabilizers
Anticonvulsants
Atypical antipsychotics
Antidepressant drugs
Anti-anxiety drugs
PART 09: Market segmentation by mechanism of action
Selective serotonin reuptake inhibitors
Serotonin-norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Benzodiazepines
Beta blockers
Others
PART 10: Geographical segmentation
Global bipolar disorder therapeutics market by
geographical segmentation 2014-2019
Bipolar disorder therapeutics market in Americas
Bipolar disorder therapeutics market in EMEA
Bipolar disorder therapeutics market in APAC
PART 11: Market drivers
Increase in prevalence of bipolar disorder
High unmet need
Increase in R&D
PART 12: Impact of drivers
PART 13: Market challenges
Use of alternative therapies
Lack of availability of standard diagnostic methods
Limited awareness of disease
Increase in patent expiries
PART 14: Impact of drivers and challenges
PART 15: Market trends
Rise in public awareness
Patient assistance programs
Strategic alliances
PART 16: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 17: Key vendor analysis
Allergan
AstraZeneca
BMS
Eli Lilly
GSK
Janssen Pharmaceuticals
PART 18: Appendix
List of abbreviatios